Status:
UNKNOWN
Effects of Magnetic Therapy and Seawater Combined in Decreasing Intraocular Presion.
Lead Sponsor:
American Society Of Thermalism And Climatology Inc
Conditions:
Primary Open Angle Glaucoma
Hypertension Ocular
Eligibility:
All Genders
18-80 years
Phase:
PHASE1
PHASE2
Brief Summary
Glaucoma is among the leading causes for blindness in the western world. Elevated intraocular pressure (IOP) has been identified as the most important risk factor. However, some patients progress desp...
Detailed Description
The two principal pathophysiological mechanisms of glaucomatous process (hydromechanical and metabolic) determine the development of two trends in the treatment of glaucoma. One treatment modality is ...
Eligibility Criteria
Inclusion
- Patient is aged 18 years or older, with glaucoma include poorly controlled open angle glaucoma (Pigmentary \& Exfoliative Glaucoma) Patient is willing to participate in the 3-month study and to adhere to the follow-up schedule.
- Patient is willing to review and sign a consent form.
Exclusion
- Prior glaucoma surgery other than laser trabeculoplasty or peripheral iridotomy.
- Patient has mental impairment such that he/she could not understand the protocol or is not in a position to provide written informed consent.
- Patient is pregnant. Patient might require other ocular surgery within the 6-month follow-up period. Having concurrent treatment with systemic steroids. Patient is under 18 years old -
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2016
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02300818
Start Date
November 1 2014
End Date
December 1 2016
Last Update
June 23 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gaviota Clinic
Newark, New Jersey, United States, 07105